Recognition of the joint contributions and shared benefits of medical resources in the Beijing-Tianjin-Hebei region--The Beijing-Tianjin-Hebei Joint Center for Cancer Prevention and Treatment was officially established

    In recent years, the incidence of malignant tumors in China has been rising, and has become one of the main public health threats for the people, with the situation of prevention and control still remaining far from good. the Beijing-Tianjin-Hebei Joint Center for Cancer Prevention and Treatment was officially established on July 24 by Peking University International Cancer Institute, Tianjin Medical University Cancer Institute & Hospital National Clinical Research Center for Cancer and The Fourth Hospital of Hebei Medical University Hebei Cancer Hospital, with the aim of facilitating a coordinated development strategy in the Beijing-Tianjin-Hebei area and the improvement of cancer prevention and treatment research level.


Prof. Ning Zhang, Vice Director, Peking University Health Science Center, Director of Dep. of Science and Research and the first Vice Director of the Beijing-Tianjin-Hebei Joint Center for Cancer Prevention and Treatment introduced the background and development plan for Beijing-Tianjin-Hebei Joint Center for Cancer Prevention and Treatment and updated the audience on the development of Peking University International Cancer Institute


Academician. Xishan Hao, Director of the National Clinical Research Center for Cancer; Director of Tianjin Cancer Institute and the first Director of the Academic Committee of Beijing-Tianjin-Hebei Joint Center for Cancer Prevention and Treatment, delivered a speech

Prof. Yunjiang Liu, Vice President of the Fourth Hospital of Hebei Medical University Hebei Cancer Hospital and the first Vice Director of the Beijing-Tianjin-Hebei Joint Center for Cancer Prevention and Treatment described the development of the Fourth Hospital of Hebei Medical University Hebei Cancer Hospital

Prof. Jihui Hao, Deputy Party Secretary and President of Tianjin Medical University Cancer Institute & Hospital updated the audience on the development of Tianjin Medical University Cancer Institute & Hospital National Clinical Research Center for Cancer

Academician Qimin Zhan, Executive Vice President of Peking University and Director of Peking University Health Science Center and the first Director of the Beijing-Tianjin-Hebei Joint Center for Cancer Prevention and Treatment, President. Jihui Hao and Vice President. Yunjiang Liu, signed the cooperation agreement

Academician Qimin Zhan,  Academician. Xishan Hao and Prof. Zhi Yao, Party Secretary of Tianjin Medical University, unveiled a plaque for the Beijing-Tianjin-Hebei Joint Center for Cancer Prevention and Treatment


Academician Qimin Zhan gave an academic lecture


Prof. Wei Lu, Party Secretary of Tianjin Medical University Cancer Institute & Hospital presided over the unveiling ceremony


  The establishment of the Beijing-Tianjin-Hebei Joint Center for Cancer Prevention and Treatment will promote the joint improvement of multidisciplinary cooperation, focusing on six major areas: clinical oncology, cancer epidemiology, cancer biology, cancer pharmacy, cancer immunology and new cancer technology, with the aim of advancing the research level of cancer prevention and treatment in Beijing-Tianjin-Hebei region and surrounding areas.

  Relying on the coordinated development strategy of Beijing-Tianjin-Hebei and facing the major needs of the country, Peking University International Cancer Institute, Tianjin Medical University Cancer Institute & Hospital-National Clinical Research Center for Cancer and The Fourth Hospital of Hebei Medical University Hebei Cancer Hospital will give full play to its advantages and resources in the field of basic cancer research and clinical practice and make exchanges and collaborations with world-renowned leading cancer centers to strive to build international first-class cancer research and treatment center.